Understanding STI Test Accuracy: What Payers Should Know About Sample Types, DBS Cards & At-Home Reliability

‍

For health plans and digital health leaders, expanding access to sexual health services is a primary goal. However, a common question remains: How accurate are at-home STI tests? As organizations look to improve Chlamydia Screening (CHL) HEDIS scores and close care gaps, understanding the nuances of STI test sensitivity and specificity is essential for maintaining clinical integrity.

The Science of Accuracy: Sensitivity vs. Specificity

When evaluating any testing program, two metrics define reliability:

• Sensitivity: The ability of a test to correctly identify those with the infection (true positive rate).
• Specificity: The ability of a test to correctly identify those without the infection (true negative rate).

The accuracy of at-home diagnostic testing relies on Nucleic Acid Amplification Testing (NAAT), the same gold-standard technology used in clinics. For many common infections, these tests offer sensitivity and specificity rates exceeding 95%. This level of at-home STI test accuracy ensures that remote screening is a clinically valid path for population health management.

Comparing Collection Methods: Swabs, Urine, and Blood

A common misconception is that one sample type is universally superior. In reality, the best STI testing method depends entirely on the infection being targeted and the anatomy of the person being tested.

Fingerprick vs. Urine Sample vs. Swab STI Test

The choice between a fingerprick vs. urine sample STI test (or a swab) is determined by where the pathogen or its antibodies reside.

• Vaginal/Rectal/Throat Swabs: For many populations, swabs are considered the "gold standard" for non-invasive testing. Research indicates that swabs often provide a higher organism load than other methods, leading to superior sensitivity. For example, while some programs rely on urine, studies show that vaginal swabs can detect up to 10% more infections for certain common STIs.
• Urine Samples: These remain a highly effective and popular option for detecting localized infections in the genital tract, particularly for male populations.
• Blood Samples: These are required for systemic infections that trigger an immune response throughout the body, such as syphilis or hepatitis, and have a high degree of reliability.

Many STI testing strategies - like our Comprehensive STI Panel - will combine these methods to maximize the possibility of detection. This is particularly helpful for patients unsure of exposure to an STI or whose symptoms aren’t immediately indicative of a specific STI.    

Dried Blood Spot Testing: A Reliable Alternative

For infections requiring blood samples, members are likely familiar with wet blood draws, such as the traditional venipuncture in the clinic. However; other alternatives exist. Dried blood spot testing (DBS) is a high-performing alternative and Tasso is a virtually pain free method for wet blood collection at home that is less invasive than in-person blood draws. 

• DBS Card Accuracy: Research shows that DBS card accuracy for systemic infections is comparable to venous blood draws, with sensitivity often exceeding 90-94% and specificity reaching 99%.
• At-Home Blood Spot STI Tests: These cards allow members to collect a sample via a simple finger prick, removing the need for a trip to a lab.

Data suggests that at-home blood spot STI tests are often more successful in a remote setting than microtainer wet blood collections, as DBS samples are more stable during transit and less prone to degradation. However, collection methods like Tasso can be a powerful tool in instances where a higher quantity of blood is needed for testing. 

See our blog comparing Dried Blood Spot Cards vs Tasso >

Navigating the False Positive STI Test

A false positive STI test can occur in any clinical setting, whether in a doctor’s office or at home. This is often a result of the test's specificity or the prevalence of the infection in a specific population.

For instance, while the chlamydia test false positive rate is extremely low, providers must still account for them in low-prevalence populations. Similarly, clinicians often watch for an hsv false positive or a higher trichomoniasis false positive rate when screening asymptomatic individuals.

The key for health plans is not just the test itself, but the clinical wrap-around services. Ash ensures that any member with an abnormal result—including a potential gonorrhea false positive or other false positive—is connected to a licensed provider for follow-up, ensuring the result is managed appropriately without creating unnecessary member distress. 

Which STI Tests are Most Accurate?

When considering which STI tests are most accurate, NAAT-based molecular tests (typically used for swabs or urine) and fourth-generation antibody/antigen tests (used in blood spots) are the benchmarks.

By moving away from older "rapid" visual tests and toward lab-processed kits, health plans can provide members with results that are just as reliable as those from a traditional clinic - ensuring member trust and satisfying relevant HEDIS measures.

At the end of the day, the best STI test is the one that gets completed. At-home methods can be easily combined into a single-package solution and help members who can’t take off work for a lab visit, fear stigma or even discrimination around STI treatment, or live in rural care deserts. 

Closing Care Gaps with Ash

At Ash, we believe that at-home health programs shouldn't force a trade-off between convenience and quality. Our platform connects your members to a pre-built network of CLIA/CAP-certified labs, ensuring that every kit processed meets rigorous clinical standards.

By offering a white-labeled member experience and multi-channel engagement, we help health plans boost HEDIS scores and provide the reliable care members deserve.

Ready to launch a high-accuracy STI screening program? Contact our team today to discuss how our flexible API, quick integration period, and 120+ verified tests can support your population health goals.